Kimberly McGregor

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 7

Top Topics

Peritoneal Dialysis

Prognostic Factors

Drug Administration

Ejection Fraction

Top Venues

JCO precision oncology

Cancer immunology, immunotherapy : CII

Lung Cancer (Auckland, N.Z.)

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Petros Christopoulos, Michal Harel, Kimberly McGregor, Yehuda Brody, Igor Puzanov, Jair Bar, Yehonatan Elon, Itamar Sela, Ben Yellin, Coren Lahav, Shani Raveh, Anat Reiner Benaim, Niels Reinmuth, Hovav Nechushtan, David Farrugia, Ernesto Bustinza-Linares, Yanyan Lou, Raya Leibowitz, Iris Kamer, Alona Zer Kuch, Mor Moskovitz, Adva Levy-Barda, Ina Koch, Michal Lotem, Rivka Katzenelson, Abed Agbarya, Gillian Price, Helen Cheley, Mahmoud Abu-Amna, Tom Geldart, Maya Gottfried, Ella Tepper, Andreas Polychronis, Ido Wolf, Adam P Dicker, David P Carbone, David R Gandara
Plasma Proteome-Based Test for First-Line Treatment Selection in Metastatic Non-Small Cell Lung Cancer. JCO precision oncology 8 (2024)
Petros Christopoulos, Michal Harel, Kimberly McGregor, Yehuda Brody, Igor Puzanov, Jair Bar, Yehonatan Elon, Itamar Sela, Ben Yellin, Coren Lahav, Shani Raveh, Anat Reiner Benaim, Niels Reinmuth, Hovav Nechushtan, David Farrugia, Ernesto Bustinza-Linares, Yanyan Lou, Raya Leibowitz, Iris Kamer, Alona Zer Kuch, Mor Moskovitz, Adva Levy-Barda, Ina Koch, Michal Lotem, Rivka Katzenelson, Abed Agbarya, Gillian Price, Helen Cheley, Mahmoud Abu-Amna, Tom Geldart, Maya Gottfried, Ella Tepper, Andreas Polychronis, Ido Wolf, Adam P Dicker, David P Carbone, David R Gandara
Plasma Proteome-Based Test for First-Line Treatment Selection in Metastatic Non-Small Cell Lung Cancer. JCO precision oncology 8 (2024)
Petros Christopoulos, Michal Harel, Kimberly McGregor, Yehuda Brody, Igor Puzanov, Jair Bar, Yehonatan Elon, Itamar Sela, Ben Yellin, Coren Lahav, Shani Raveh, Anat Reiner Benaim, Niels Reinmuth, Hovav Nechushtan, David Farrugia, Ernesto Bustinza-Linares, Yanyan Lou, Raya Leibowitz, Iris Kamer, Alona Zer Kuch, Mor Moskovitz, Adva Levy-Barda, Ina Koch, Michal Lotem, Rivka Katzenelson, Abed Agbarya, Gillian Price, Helen Cheley, Mahmoud Abu-Amna, Tom Geldart, Maya Gottfried, Ella Tepper, Andreas Polychronis, Ido Wolf, Adam P Dicker, David P Carbone, David R Gandara
Plasma Proteome-Based Test for First-Line Treatment Selection in Metastatic Non-Small Cell Lung Cancer. JCO precision oncology 8 (2024)
Petros Christopoulos, Michal Harel, Kimberly McGregor, Yehuda Brody, Igor Puzanov, Jair Bar, Yehonatan Elon, Itamar Sela, Ben Yellin, Coren Lahav, Shani Raveh, Anat Reiner Benaim, Niels Reinmuth, Hovav Nechushtan, David Farrugia, Ernesto Bustinza-Linares, Yanyan Lou, Raya Leibowitz, Iris Kamer, Alona Zer Kuch, Mor Moskovitz, Adva Levy-Barda, Ina Koch, Michal Lotem, Rivka Katzenelson, Abed Agbarya, Gillian Price, Helen Cheley, Mahmoud Abu-Amna, Tom Geldart, Maya Gottfried, Ella Tepper, Andreas Polychronis, Ido Wolf, Adam P Dicker, David P Carbone, David R Gandara
Plasma Proteome-Based Test for First-Line Treatment Selection in Metastatic Non-Small Cell Lung Cancer. JCO precision oncology 8 (2024)
Tyler J Nielsen, Matthew Gordon Varga, Catherine T Cronister, Brian Z Ring, Robert S Seitz, Douglas T Ross, Brock L Schweitzer, Kimberly McGregor
The 27-gene IO score is associated with efficacy of PD-1/L1 inhibitors independent of FGFR expression in a real-world metastatic urothelial carcinoma cohort. Cancer immunology, immunotherapy : CII (2023)
Carlotta Antoniotti, Alessandra Boccaccino, Robert S Seitz, Mirella Giordano, Aurelie Catteau, Daniele Rossini, Filippo Pietrantonio, Lisa Salvatore, Kimberly McGregor, Francesca Bergamo, Veronica Conca, Simone Leonetti, Federica Morano, Giorgio Papiani, Emiliano Tamburini, Maria Bensi, Sabina Murgioni, Douglas Teller Ross, Alessandro Passardi, Isabelle Boquet, Tyler J Nielsen, Jerome Galon, Matthew Gordon Varga, Brock L Schweitzer, Chiara Cremolini
An immune-related gene expression signature predicts benefit from adding atezolizumab to FOLFOXIRI plus bevacizumab in metastatic colorectal cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Alexa B Schrock, Russell W Madison, Mark Rosenzweig, Justin M Allen, Rachel L Erlich, Siao-Yi Wang, Tarek Chidiac, Vodur Suresh Reddy, Jonathan W Riess, Ahmet Ersin Yassa, Abdur Shakir, Vincent A Miller, Brian M Alexander, Jeffrey Venstrom, Kimberly McGregor, Siraj M Ali
Patients with NSCLCs Harboring Internal Inversions or Deletion Rearrangements of the ALK Gene Have Durable Responses to ALK Kinase Inhibitors. Lung Cancer (Auckland, N.Z.) 11 (2020)